Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, today announced that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.

Why COP28 is the most important COP since the Paris Agreement

Share this article Arabian sand gazelles on the edge of the city of Dubai, in the UAE, November 2023. Credit: Andrea DiCenzo/Getty Images. On 30

November 22, 2023

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses

The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can

August 19, 2024

Experts call for clear rules governing human embryo research

Clear rules governing human embryo research must be established to enable regulators, researchers and funders to assess whether stem cell-generated models should be considered as

June 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.